Skip to content

Clinical Efficacy of Polynucleotides TMJ Injections Compared to Physiotherapy.

Clinical Efficacy of Polynucleotides TMJ Injections Compared to Physiotherapy. A 3-months Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06375330
Enrollment
60
Registered
2024-04-19
Start date
2023-04-18
Completion date
2024-04-08
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TMJ Disease, TMJ Pain

Keywords

polynucleotides, TMJ, VAS, Physiotherapy, Hyaluronic acid, Laterality

Brief summary

The main objective of the present study is the evaluation of the clinical efficacy of the intra-articular administration of polynucleotides in association with hyaluronic acid in the improvement of the subjective and objective manifestations of arthrosis of the temporomandibular joint compared to normal clinical management which involves Physiotherapy.

Interventions

DEVICEPoliArt

PoliArt injections

Sponsors

Sidoti & Tartaglia Srl
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients who signed the informed consent * age \>18; * male and female sex; * affected by temporomandibular arthrosis

Exclusion criteria

* Patients treated with painkillers and anti-inflammatories; * patients suffering from rheumatoid arthritis with TMJ involvement; * patients with a positive history of allergies to products of fish origin; * patients suffering from alteration of the internal TMJ; * patients suffering from mandibular condylar hyperplasia; * patients suffering from myofascial pain syndrome; * patients unable to express their consent for participation in the study; * patients suffering from psychiatric and behavioral disorders; * patients suffering from oncological and onco-haematological pathologies with compromised general clinical status.

Design outcomes

Primary

MeasureTime frameDescription
Maximum mouth opening3 monthsThe primary objective is to evaluate the improvement of symptoms over time in terms of maximum mouth opening of patients (which in most cases is limited) treated with polynucleotides in association with hyaluronic acid compared to patients treated with physiotherapy exercises.

Secondary

MeasureTime frameDescription
Lateral movements improvements3 monthsEvaluation of the improvement of symptoms over time in terms of lateral movements in patients treated with polynucleotides in association with hyaluronic acid compared to patients treated with physiotherapy exercises. Lateral movements of the mandible were measured in millimeters as the distance between upper and lower midline at maximum lateral excursion; if the midlines were not centered at maximum intercuspation position, the midline shift in millimeters was added (if contralateral) or subtracted (if ipsilateral) to the recorded measurement.
Pain assessment3 monthsEvaluation of the reduction of pain in the two groups over time with Visual Analogue Scale (VAS). VAS score was recorded on a Likert scale ranging from 1 to 10, according to the subjective pain felt by the patient.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026